In a small group of patients with ANKL and ENKTL, JAK2 gain was associated with gains of the neighboring immune evasion-associated CD274 (PD-L1) and CD273 (PD-L2) genes [62]. The gene discussed is PDCD1LG2; the disease is aggressive NK-cell leukemia.